Prometheus Labs Gets $260M in Debt Financing

Xconomy San Diego — 

San Diego-based Prometheus Laboratories, which develops specialty pharmaceuticals and diagnostic tests, says today it has secured $260 million in financing that consists of a $210 million loan and a $50 million line of credit. The company says proceeds will be used to finance the acquisition of more therapeutic and diagnostic products, and to refinance existing indebtedness.